Premature cardiovascular disease in chronic renal failure.

There is a remarkable lack of reliable information about the determinants of risk of cardiovascular disease (CVD) among patients with chronic renal failure. Indeed, such patients have often been deliberately excluded from randomised trials of treatments of CVD, perhaps because of concerns about drug...

Full description

Bibliographic Details
Main Authors: Baigent, C, Burbury, K, Wheeler, D
Format: Journal article
Language:English
Published: 2000
_version_ 1797081086423990272
author Baigent, C
Burbury, K
Wheeler, D
author_facet Baigent, C
Burbury, K
Wheeler, D
author_sort Baigent, C
collection OXFORD
description There is a remarkable lack of reliable information about the determinants of risk of cardiovascular disease (CVD) among patients with chronic renal failure. Indeed, such patients have often been deliberately excluded from randomised trials of treatments of CVD, perhaps because of concerns about drug safety. But the absolute risk of CVD among them may be large, so the potential absolute benefits of treatments may also be large, and may well exceed any increased hazards. Hence, as well as further investigation of the underlying mechanisms of cardiac disease, it would be helpful to have some large-scale randomised trials in a wide range of renal patients of interventions (such as cholesterol-lowering drugs, antihypertensives, aspirin, B-vitamins, and antioxidant vitamins) that are of proven or suspected benefit in other settings. If safe and effective treatments can be identified, and started early in the natural history of renal failure, the exceptionally high risk of CVD experienced by these patients could be decreased before and after end-stage renal failure has occurred.
first_indexed 2024-03-07T01:09:33Z
format Journal article
id oxford-uuid:8c871472-7193-46aa-9e54-995918f29587
institution University of Oxford
language English
last_indexed 2024-03-07T01:09:33Z
publishDate 2000
record_format dspace
spelling oxford-uuid:8c871472-7193-46aa-9e54-995918f295872022-03-26T22:45:05ZPremature cardiovascular disease in chronic renal failure.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8c871472-7193-46aa-9e54-995918f29587EnglishSymplectic Elements at Oxford2000Baigent, CBurbury, KWheeler, DThere is a remarkable lack of reliable information about the determinants of risk of cardiovascular disease (CVD) among patients with chronic renal failure. Indeed, such patients have often been deliberately excluded from randomised trials of treatments of CVD, perhaps because of concerns about drug safety. But the absolute risk of CVD among them may be large, so the potential absolute benefits of treatments may also be large, and may well exceed any increased hazards. Hence, as well as further investigation of the underlying mechanisms of cardiac disease, it would be helpful to have some large-scale randomised trials in a wide range of renal patients of interventions (such as cholesterol-lowering drugs, antihypertensives, aspirin, B-vitamins, and antioxidant vitamins) that are of proven or suspected benefit in other settings. If safe and effective treatments can be identified, and started early in the natural history of renal failure, the exceptionally high risk of CVD experienced by these patients could be decreased before and after end-stage renal failure has occurred.
spellingShingle Baigent, C
Burbury, K
Wheeler, D
Premature cardiovascular disease in chronic renal failure.
title Premature cardiovascular disease in chronic renal failure.
title_full Premature cardiovascular disease in chronic renal failure.
title_fullStr Premature cardiovascular disease in chronic renal failure.
title_full_unstemmed Premature cardiovascular disease in chronic renal failure.
title_short Premature cardiovascular disease in chronic renal failure.
title_sort premature cardiovascular disease in chronic renal failure
work_keys_str_mv AT baigentc prematurecardiovasculardiseaseinchronicrenalfailure
AT burburyk prematurecardiovasculardiseaseinchronicrenalfailure
AT wheelerd prematurecardiovasculardiseaseinchronicrenalfailure